In MYC-driven small cell lung cancer, tumors rely heavily on the arginine synthesis pathway, and depleting arginine using pegylated arginine deiminase can significantly inhibit tumor growth and improve survival rates in mouse tumor models (Chalishazar et al., 2019). This evidence concerns the gene MYC and neoplasm.